Mitochondrial Dysfunction Biomarkers
Mitochondrial Dysfunction Biomarkers is a biomarker of effect that specifically indicates impairments in mitochondrial structure, function, or dynamics, serving as measurable indicators of cellular energy metabolism disruption underlying various pathological conditions.
1.2K
Publications
69.9K
Citations
8.9K
Authors
2.2K
Institutions
Publications per year
2017–2026
692
Parents
1.2K
Association between mitochondrial dysfunction and severity and outcome of septic shock
David Brealey, M. P. Brand, Iain P. Hargreaves et al. · The Lancet · 2002 · 1.5K citations
Mitchell R. McGill, Matthew R. Sharpe, C. David Williams et al. · Journal of Clinical Investigation · 2012 · 763 citations · Full text
Pharmacy, Pharmacology, Toxicology +17
Ian A. Trounce, Yoon L. Kim, Albert S. Jun et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 1996 · 745 citations
1–5 of 1.2K
8.9K
8
h-index
8
h-index
7
h-index
7
h-index
7
h-index
1–5 of 8.9K
2.2K
University of Pennsylvania
Philadelphia, United States
21 h-index
121 publications
8.2K citations
Inserm
Paris, France
21 h-index
142 publications
8.3K citations
Harvard University
Cambridge, United States
20 h-index
99 publications
6K citations

Johns Hopkins University
Baltimore, United States
19 h-index
76 publications
5.6K citations
National Institutes of Health
Bethesda, United States
17 h-index
95 publications
5.2K citations
Universitat de Barcelona
Barcelona, Spain
16 h-index
74 publications
4K citations
University of California San Diego
San Diego, United States
16 h-index
49 publications
3.5K citations
Instituto de Salud Carlos III
Madrid, Spain
15 h-index
76 publications
4.4K citations
1–8 of 2.2K
40 publications · 2.2K citations
27
h-index
39 publications · 2.1K citations
24
h-index
35 publications · 1.6K citations
23
h-index
Repository · 23 publications · 1.5K citations
18
h-index
IJMS · 25 publications · 738 citations
17
h-index
1–5